Showing results (11-20 of 223) with videos related to
Sort By:
Pageof 23
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 23, 2013
Monoamine neurocircuitry in depression and strategies for new treatmentsMichel Hamon, Pierre BlierThe International Journal of Neuropsychopharmacology|August 6, 2003
Enhancing action of LSD on neuronal responsiveness to serotonin in a brain structure involved in obsessive-compulsive disorderTarek Zghoul, Pierre BlierPeptides|July 27, 2005
Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugsGabriella Gobbi, Pierre BlierNeuropsychiatric Disease and Treatment|July 14, 2011
The noradrenergic symptom cluster: clinical expression and neuropharmacologyPierre Blier, Mike BrileyCurrent Drug Targets|February 16, 2006
Catecholaminergic strategies for the treatment of major depressionPhilippe Tremblay, Pierre BlierEuropean Journal of Pharmacology|October 22, 2008
Neurokinin-1 receptor antagonists modulate brain noradrenaline and serotonin interactionsNasser Haddjeri, Pierre BlierProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 24, 2006
Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorderMostafa El Mansari, Pierre BlierThe Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neuronsSteven T Szabo, Pierre BlierThe Journal of Clinical Psychiatry|December 13, 2005
Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxietyPierre Blier, Steve T SzaboMedecine Sciences : M/S|January 25, 2021
[A review of the antidepressant properties of ketamine]Charles Y Desfossés, Pierre BlierPageof 23